Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out
24. Dezember 2024 08:30 ET
|
Carmell Corporation
Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out
Trent Renta Promoted to Chief Operating Officer at Olansky Dermatology & Aesthetics in Atlanta, Georgia
18. November 2024 16:44 ET
|
Olansky Dermatology & Aesthetics
Trent Renta promoted to Chief Operating Officer
at Olansky Dermatology & Aesthetics in Atlanta, Georgia.
Olansky Dermatology & Aesthetics co-founder Dr. David Olansky retires after more than 40 years of clinical practice
10. Oktober 2024 12:24 ET
|
Olansky Dermatology & Aesthetics
Olansky Dermatology & Aesthetics co-founder Dr. David Olansky
retires after more than 40 years of clinical practice.
LeaderMed Group and Combiphar Form Joint Venture on LM-008, a Novel GLP-1 Dual Agonist, Targeting Indonesia's High Diabetes and/or Obesity Prevalence
30. September 2024 22:00 ET
|
LeaderMed Group; Combiphar
LeaderMed and Combiphar form a joint venture to tackle Indonesia’s diabetes and obesity crisis with LM-008 and UltraSculpt, launching a Phase 3 trial.
ASDS Experts Share Procedural Dermatology Techniques at Unique Hands-on Course With Innovative 3D Technology
16. September 2024 07:00 ET
|
American Society for Dermatologic Surgery
Schaumburg, IL, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The American Society for Dermatologic Surgery (ASDS) welcomed more than 50 dermatologic surgeons and dermatology residents to its new course, “ASDS...
Carmell Corporation Launches Skincare Partnership With Ladies Playbook to Support and Celebrate NFL Sports Community
05. September 2024 08:30 ET
|
Carmell Corporation
PITTSBURGH, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Company” or “Carmell”), today announced a strategic...
[Latest] Global Aesthetics Injectables Market Size/Share Worth USD 35,976.2 Million by 2033 at a 9.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
13. August 2024 00:30 ET
|
Custom Market Insights
Austin, TX, USA, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Aesthetics Injectables Market Size, Trends and Insights By Product Type...
[Latest] Global Medical Aesthetics Market Size/Share Worth USD 36,168.8 Million by 2033 at a 8.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
06. August 2024 03:30 ET
|
Custom Market Insights
Austin, TX, USA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Medical Aesthetics Market Size, Trends and Insights By Product Type (Aesthetic...
Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index
29. Juli 2024 08:30 ET
|
Carmell Corporation
Carmell Corp (Nasdaq: CTCX) announced the appointment of Kendra Bracken-Ferguson as CEO effective July 30, 2024 with Rajiv Shukla continuing as Chairman.
Hydroxyapatite Market Size is Projected to Reach USD 4.4 billion, Garnering a 6.0% CAGR by 2034 | Exclusive Report by Transparency Market Research, Inc.
03. Juli 2024 08:34 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. - , July 03, 2024 (GLOBE NEWSWIRE) -- The hydroxyapatite market was projected to attain US$ 2.3 billion in 2023. It is...